Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for... Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. Show more
SEATTLE, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the...
clonoSEQ is the first and only assay to receive Medicare coverage for MRD assessment in MCL Coverage leverages new Medicare episode pricing established based on updated clonoSEQ gapfill rate...
SEATTLE, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...
SEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.41 | -24.1852487136 | 5.83 | 5.83 | 4.33 | 1417929 | 4.75816664 | CS |
4 | -0.36 | -7.53138075314 | 4.78 | 6.7 | 4.33 | 1173078 | 5.2453349 | CS |
12 | -0.13 | -2.85714285714 | 4.55 | 6.7 | 3.981 | 1054815 | 4.94756581 | CS |
26 | 0.88 | 24.8587570621 | 3.54 | 6.7 | 2.99 | 1244875 | 4.33485748 | CS |
52 | 0.02 | 0.454545454545 | 4.4 | 6.7 | 2.28 | 1397878 | 3.99212558 | CS |
156 | -22.96 | -83.8568298028 | 27.38 | 30.51 | 2.28 | 1282973 | 7.47089103 | CS |
260 | -24.06 | -84.4803370787 | 28.48 | 71.25 | 2.28 | 1131116 | 17.84640225 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales